InvestorsHub Logo
Followers 27
Posts 887
Boards Moderated 0
Alias Born 12/27/2013

Re: Cbucco post# 41392

Wednesday, 11/08/2017 6:23:17 PM

Wednesday, November 08, 2017 6:23:17 PM

Post# of 48316
I don't post much but wanted to chime in with the recent developments. I once was a hater of ONCS I mean I couldn't stand the company but about a year ago I spoke with Punit in San Diego and it's then that I understood a lot of what ONCS was doing and a lot of how tiny biotech's work. Most of the time the market ignores these companies and it takes phenomenal results plus perfect timing to really truly prosper. Punit told me back then that the true value of ONCS wouldn't be recognized until a deal was struck. Well I think with the addition of Dan (yes has a past but it's all speculation as to what really happened) this deal is imminent. Reason the more time goes by the more expensive OncoSec gets because of the risk factor is diminished. Merck knows I believe what OncoSec can do and with Punit running the show his inexperience in deal making was hindering a possible deal. Licensing is where the money truly is for OncoSec but Merck I believe will do everything they can to not allow this to happen. Dan is there for negotiation purposes period!! Again this is my take and this is what I believe do your own DD and draw your own conclusions but I think the story is becoming more clear.